Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth
Update your Virtual Booth on PharmaCompass, ask us
About
CPhI WW FrankfurtCPhI WW Frankfurt
Not Confirmed
Not Confirmed
28-30 October, 2025
Fall Technical MeetingFall Technical Meeting
Not Confirmed
Not Confirmed
05-07 October, 2025
The MedTech ConferenceThe MedTech Conference
Not Confirmed
Not Confirmed
05-08 October, 2025
List your booth number for exhibitions, ask us
CONTACT DETAILS
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
Events
Webinars & Exhibitions
CPhI WW FrankfurtCPhI WW Frankfurt
Industry Trade Show
Not Confirmed
28-30 October, 2025
Fall Technical MeetingFall Technical Meeting
Industry Trade Show
Not Confirmed
05-07 October, 2025
The MedTech ConferenceThe MedTech Conference
Industry Trade Show
Not Confirmed
05-08 October, 2025
Digital content
INTERVIEW #SpeakPharma
[Sponsored by another company]https://www.pharmacompass.com/speak-pharma/we-bridge-the-gap-between-chemistry-and-performance-to-deliver-precise-optimized-micronization-for-complex-apis
VLOG #PharmaReel
[Sponsored by another company]DATA COMPILATION #PharmaFlow
[Sponsored by another company]https://www.pharmacompass.com/radio-compass-blog/global-api-micronization-market-set-to-surge-49-by-2030-led-by-specialized-industry-pioneers
29 Sep 2025
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2025/09/29/3157572/0/en/Vor-Bio-Announces-Late-Breaking-Poster-Presentation-of-Phase-3-Primary-Sj%C3%B6gren-s-Disease-Clinical-Study-at-ACR-Convergence-2025.html
17 Sep 2025
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2025/09/17/3152015/0/en/Vor-Bio-Announces-Oral-Presentation-of-48-Week-China-Phase-3-Generalized-Myasthenia-Gravis-Clinical-Study-at-AANEM.html
28 Aug 2025
// FIERCE PHARMA
https://www.fiercepharma.com/pharma/remegen-vor-bio-score-again-telitacicept-time-igan
19 Aug 2025
// FIERCE BIOTECH
https://www.fiercebiotech.com/biotech/chinas-remegen-sells-asia-rights-vegffgf-eye-drug-180m-deal
18 Aug 2025
// PR NEWSWIRE
https://www.prnewswire.com/news-releases/remegen-and-santen-enter-into-exclusive-licensing-agreement-for-ophthalmic-innovative-drug-rc28-e-in-greater-china-and-asian-countries-302532212.html
13 Aug 2025
// PR NEWSWIRE
https://www.prnewswire.com/news-releases/telitacicept-meets-primary-endpoint-in-phase-iii-trial-for-primary-sjogrens-syndrome-in-china-302528868.html
ABOUT THIS PAGE